Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.450
-0.070 (-4.61%)
At close: Mar 5, 2026, 4:00 PM EST
1.452
+0.002 (0.14%)
After-hours: Mar 5, 2026, 6:08 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $3.69 million as of March 5, 2026. Its market cap has decreased by -74.44% in one year.
Market Cap
3.69M
Enterprise Value
-2.19M
1-Year Change
-74.44%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $3.69M, a decrease of -93.55%. That is a compound annual growth rate of -44.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 3.87M | -33.79% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 4.64M |
| BioRestorative Therapies | 4.47M |
| Indaptus Therapeutics | 4.22M |
| Decoy Therapeutics | 4.21M |
| GeoVax Labs | 4.17M |
| Galmed Pharmaceuticals | 4.02M |
| Matinas BioPharma Holdings | 3.87M |
| HCW Biologics | 3.80M |